Preformulation Intermediates Market

Preformulation intermediates Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • April 2020
  • REP-GB-7845
Preformulation Intermediates Market

  • US$5,000
  • US$7,500
  • US$10,000

This Preformulation Intermediates market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Preformulation Intermediates market.

Preformulation intermediates Market: Market Insights

Preformulation intermediate is used for the Direct compressible and that comprises active substance and excipients. Preformulation intermediate is a combination of substance that is used as a raw material for producing pharmaceutical products and quality of preformulation intermediate has signifant effect on safety and efficacy of medication. Preformulation intermediates are the components of both quality and cost of the pharmaceutical products. Manufacturing of pharmaceutical products occurs in two steps, firstly raw material convert into preformulation intermediate or active pharmaceutical ingredients and then final product create by mixing of preformulation intermediate and other non-active ingredients such as excipient and pressing into tablets. Market of preformulation intermediates is too competitive with other producers. Preformulation intermediates is used in Dermal, Ophthalmic, Nasal and OTC drug formulations. Market of preformulation intermediate comprises different product segment such direct compression granules and capsule filling and micro encapsulated preformulation intermediates. Preformulation intermediate is used in the selection of drug candidate, selection of formulation components, active pharmaceutical ingredients and among others drug manufacturing process. Basically Preformulation intermediate is used in formulation and development of new dosage form. Process of preformulation begin when synthesized drug show pharmacologic indication in animal models to evaluation in man.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?

Preformulation intermediate Market: Market Dynamic

The growing production of Preformulation intermediate for pharmaceutical product development is expected to drive the revenue generation in the global Preformulation intermediate market. The increasing demand for Preformulation intermediate in new applications for emerging fields such as development of new dosage form and Continuous research in biopharmaceuticals is rising the development of novel products has been increased. Preformulation intermediate manufacturing method is used for developments of pharmaceutical product especially for tablets because 90 % of therapeutic compound are administered by oral route so for which tablet dosage form is more preferable and . However stringent regulatory requirement, government regulations and unfavorable drug price control policies across various countries and market forces are expected to restrain the growth of the global Preformulation intermediate market

Preformulation market Insight Forecast to 2026: Overview

The global market for Preformulation intermediate is expected to generate significant revenue with a moderate growth over the forecast period. Rising in demand for biopharmaceuticals and technological advancements such as hydrogenation, Amination, electrochemisty, acetylene other technologies are used to manufacture these intermediates and other applications thus there exists a high competition among local and regional players in the Preformulation intermediate market. Among product types, the Preformulation intermediate including generic drug, over the counter drugs and innovative drugs is expected to lead the global Preformulationintermediate market over the forecast period. Increasing number of FDA approved new molecular entities and higher price commanded by innovative APIs is expected to increasing market of preformulation intermediate. Research centers and institutes in the end user segment is also expected to contribute high revenue share in the globalPreformulation intermediate market as a majority of demand generated from end user segment.

Preformulation intermediate market Insights, Forecast to 2026: Regional Outlook

Geographically, the global Preformulation market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). Among these, North America is expected to be the dominant regional market for Preformulation intermediate owing to high presence of major pharmaceutical companies and better infrastructure. Also, the set-up of numerous research laboratories in the region is further expected to drive revenue generation in the region over forecast period and in this region is attributed to increasing prevalence of diabetes and cardiac disease.The Preformulation intermediate market inAsia Pacific excluding Japan is expected to grow due to presence of large number of contract manufacturing organization. Europe is expected to register second large share in the global Preformulation intermediate market.

Preformulation intermediate Market Insights, Forecast to 2026:  Key Players

The global Preformulation intermediate market registers presence of large number of domestic manufacturers. Examples of some of the key players operating in the global Preformulation intermediate market are Pfizer Inc., Novartis International AG, Merck & Co., Teva Pharmaceutical Industries Ltd., Mylan, Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, AstraZeneca Plc., Bristol-Myers Squibb, and GlaxoSmithKline plc. among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Preformulation Intermediates Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Preformulation intermediate Market: Segmentation

Global Preformulation intermediate market can be segmented on the basis of Drug Type, Active pharmaceutical ingredients, Type of drug, application, Synthesis and end user.

Based on Drug Type and methods, the global Preformulation intermediate market is segmented as:

  • Innovative Drugs
  • Generic Prescription
  • Over-the-counter (OTC) Drugs

Based on Active pharmaceutical ingredients, the global Preformulation intermediate market is segmented as:

  • Chemical API
  • Biological API

Based on Application, the global Preformulation intermediate market is segmented as:

  • Oncology Drugs
  • Non-steroidal Anti-inflammatory Drugs
  • Cardiovascular Drugs
  • Anti-diabetic Drugs
  • Neurology Drugs
  • Musculoskeletal drugs
  • Others Therapeutic Applications

Based on Synthesis, the global Preformulation intermediate market is segmented as:

  • Synthetic APIs Market
  • Biotech APIs Market

Based on end user, the global Preformulation intermediate market is segmented as:

  • Research Centers and Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Preformulation Intermediates Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Preformulation Intermediates Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology